Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia : A Clinical Perspective
Joint Authors
Přikrylová Kučerová, Hana
Vrzalová, Michaela
Češková, Eva
Přikryl, Radovan
Source
Schizophrenia Research and Treatment
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-7, 7 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-05-07
Country of Publication
Egypt
No. of Pages
7
Main Subjects
Abstract EN
Approximately 80% of patients with the first-episode schizophrenia reach symptomatic remission after antipsychotic therapy.
However, within two years most of them relapse, mainly due to low levels of insight into the illness and nonadherence to their oral medication.
Therefore, although the formal data available is limited, many experts recommend prescribing long-acting injectable second-generation antipsychotics (mostly risperidone or alternatively paliperidone) in the early stages of schizophrenia, particularly in patients who have benefited from the original oral molecule in the past and agree to receive long-term injectable treatment.
Early application of long-acting injectable second-generation antipsychotics can significantly reduce the risk of relapse in the future and thus improve not only the social and working potential of patients with schizophrenia but also their quality of life.
American Psychological Association (APA)
Přikryl, Radovan& Přikrylová Kučerová, Hana& Vrzalová, Michaela& Češková, Eva. 2012. Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia : A Clinical Perspective. Schizophrenia Research and Treatment،Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-497013
Modern Language Association (MLA)
Přikryl, Radovan…[et al.]. Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia : A Clinical Perspective. Schizophrenia Research and Treatment No. 2012 (2012), pp.1-7.
https://search.emarefa.net/detail/BIM-497013
American Medical Association (AMA)
Přikryl, Radovan& Přikrylová Kučerová, Hana& Vrzalová, Michaela& Češková, Eva. Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia : A Clinical Perspective. Schizophrenia Research and Treatment. 2012. Vol. 2012, no. 2012, pp.1-7.
https://search.emarefa.net/detail/BIM-497013
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-497013